(259 days)
Not Found
No
The device is a quality control material used to verify the linearity of laboratory testing procedures for specific protein analytes. There is no mention of any computational algorithms, data analysis, or learning processes that would indicate the use of AI or ML. The description focuses on the physical composition and intended use as a linearity standard.
No.
The device is a quality control material intended for in vitro diagnostic use to confirm the proper calibration and linear operating range of laboratory testing procedures, not for treating or diagnosing patients.
No
Explanation: The device is a quality control material intended to simulate patient samples and detect analytical deviations in laboratory testing procedures. It is not used to diagnose a disease in a patient. Instead, it is used to ensure the accuracy and proper functioning of testing equipment.
No
The device description clearly states it is a "human based, five level set of QC material," indicating it is a physical substance, not software.
Yes, this device is an IVD (In Vitro Diagnostic).
Here's why:
- Explicit Statement: The "Intended Use / Indications for Use" section explicitly states: "The Audit MicroCV Protein Linearity Set is 'For In Vitro Diagnostic Use Only.'"
- Intended Use: The device is intended to "simulate human patient serum samples and to detect systematic analytical deviations of laboratory testing procedures" for specific protein analytes. This aligns with the definition of an IVD, which is used to examine specimens derived from the human body to provide information for diagnostic purposes.
- Device Description: The description confirms it is a "human based, five level set of QC material" used to "confirm the proper calibration, linear operating range, and reportable range of the analytes listed." This is a typical function of quality control materials used in IVD testing.
- Intended User / Care Setting: The intended user is involved in "laboratory testing procedures," which is the setting where IVD tests are performed.
N/A
Intended Use / Indications for Use
The Audit™ MicroCV™ Protein Linearity is assayed quality control material consisting of five levels protein (human) based serum. Each level contains Alpha-1-Antitrypsin, Complement C3, Complement C4, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M and Transferrin analytes. The five levels demonstrate a linear relationship to each other for Alpha-1-Antitrypsin, Complement C3, Complement C4, Immunoglobulin A, Immunoglobulin A, Immunoglobulin M, and Transferrin analytes. It is intended to simulate human patient serum samples and to detect systematic analytical deviations of laboratory testing procedures for Alpha-1-Antitrypsin, Complement C3, Complement C4, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M, and Transferrin. The product is intended for use with quantitative assays on the indicated analyzer provided in the labeling. The Audit MicroCV Protein Linearity Set is "For In Vitro Diagnostic Use Only."
Product codes
JJY
Device Description
The Audit™ MicroCVTM Protein Linearity Set is a human based, five level set of QC material, with each level containing seven analytes: Aipha-1-Antitrypsin, Complement C3, Complement C4, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M, and Transferrin. It is used to confirm the proper calibration, linear operating range, and reportable range of the analytes listed. Level A is near the lower limit level and Level E has concentrations near the upper limit of instruments. Levels B - D are related by linear dilution of Level A and Level E.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Stability studies have been performed to determine the open vial stability and shelf life for the Audit™ MicroCVTM Protein Linearity Set. All supporting data is retained on file at Aalto Scientific, Ltd. Product claims are as follows:
Open Vial Stability: Once a vial has been opened, all analytes will be stable for 1 day when stored tightly capped at 2 - 8° C.
Shelf Life: One year, when stored unopened at 2 - 8° C.
Note: Real time studies are ongoing to support the shelf life of this product.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 862.1660 Quality control material (assayed and unassayed).
(a)
Identification. A quality control material (assayed and unassayed) for clinical chemistry is a device intended for medical purposes for use in a test system to estimate test precision and to detect systematic analytical deviations that may arise from reagent or analytical instrument variation. A quality control material (assayed and unassayed) may be used for proficiency testing in interlaboratory surveys. This generic type of device includes controls (assayed and unassayed) for blood gases, electrolytes, enzymes, multianalytes (all kinds), single (specified) analytes, or urinalysis controls.(b)
Classification. Class I (general controls). Except when intended for use in donor screening tests, quality control materials (assayed and unassayed) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.
0
K101Z16
510(k) Summary
A. Submitter
JAN 1 4 2011
く
Aalto Scientific, Ltd. 1959 Kellogg Ave. Carlsbad, CA 92008 (760) 431-7922 Telephone: (760) 431-6824 Fax:
B. Contact Person
E-mail: Dessi Lyakov Telephone: (760) 431-7922 Ext. 118 E-mail: dlyakov(@aaltoscientific.com
C. Date of Summary Preparation
December 03, 2010
D. Device Identification
Product Trade Name: Common Name: Classification Name: Device Classification: Regulation Number: Panel: Product Code:
Audit™ MicroCVTM Protein Linearity Set Protein Linearity Assay QC Material Class I 21 CFR 862.1660 75 JJY
E. Device to Which Substantial Equivalence is Claimed
Audit™ MicroCVTM General Chemistry Linearity Set Aalto Scientific, Ltd., Carlsbad, CA K042318
1
F. Description of the Device
The Audit™ MicroCVTM Protein Linearity Set is a human based, five level set of QC material, with each level containing seven analytes: Aipha-1-Antitrypsin, Complement C3, Complement C4, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M, and Transferrin. It is used to confirm the proper calibration, linear operating range, and reportable range of the analytes listed. Level A is near the lower limit level and Level E has concentrations near the upper limit of instruments. Levels B - D are related by linear dilution of Level A and Level E.
G. Statement of Intended Use
The Audit™ MicroCV™ Protein Linearity is assayed quality control material consisting of five levels protein (human) based serum. Each level contains Alpha-1-Antitrypsin, Complement C3. Complement C4, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M and Transferrin analytes. The five levels demonstrate a linear relationship to each other for Alpha-1-Antitrypsin, Complement C3, Complement C4, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M, and Transferrin analytes. It is intended to simulate human patient serum samples and to detect systematic analytical deviations of laboratory testing procedures for Alpha-1-Antitrypsin. Complement C3, Complement C4, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M, and Transferrin. The product is intended for use with quantitative assays on the indicated analyzer provided in the labeling. The Audit MicroCV Protein Linearity Set is "For In Vitro Diagnostic Use Only."
I. Summary of Performance Data
Stability studies have been performed to determine the open vial stability and shelf life for the Audit™ MicroCVTM Protein Linearity Set. All supporting data is retained on file at Aalto Scientific, Ltd. Product claims are as follows:
. Open Vial Stability: Once a vial has been opened, all analytes will be stable for 1 day when stored tightly capped at 2 - 8° C.
Shelf Life: One year, when stored unopened at 2 - 8° C. Note: Real time studies are ongoing to support the shelf life of this product.
2
| Characteristics | Audit™ MicroCV™ Protein Linearity
Set
(K101216) | Audit™ MicroCV™ General Chemistry
Linearity Set
(K042318) |
|--------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Intended Use | The Audit™ MicroCV™ Protein
Linearity is assayed quality control
material consisting of five levels
protein (human) based serum. Each
level contains Alpha-1-Antitrypsin,
Complement C3, Complement C4,
Immunoglobulin G, Immunoglobulin
A, Immunoglobulin M and
Transferrin analytes. The five levels
demonstrate a linear relationship to
each other for Alpha-1-Antitrypsin,
Complement C3, Complement C4,
Immunoglobulin G, Immunoglobulin
A, Immunoglobulin M, and
Transferrin analytes. It is intended to
simulate human patient serum
samples and to detect systematic
analytical deviations of laboratory
testing procedures for Alpha-1-
Antitrypsin, Complement C3,
Complement C4, Immunoglobulin G,
Immunoglobulin A, Immunoglobulin
M, and Transferrin. The product is
intended for use with quantitative
assays on the indicated analyzer
provided in the labeling. The Audit
MicroCV Protein Linearity Set is
"For In Vitro Diagnostic Use Only." | Audit™ MicroCV™ General Chemistry
Linearity Set is assayed quality control
material consisting of human based
serum. It is intended to simulate human
patient serum samples for the purpose
of monitoring the precision and to
detect systematic analytical deviations
of laboratory testing procedures. This
product may also be used as unassayed
quality control material for these same
analytes. |
| Number of
Analytes per vial | 7 | 30 |
| Number of
levels per set | 5 | 5 |
| Contents | 5 x 2 mL | 5 x 5 mL |
| Matrix | Human Based Serum | Human Based Serum |
| Type of
Analytes | Clinical Chemistry | General Chemistry |
:
H. Technical Characteristics Compared to Predicate Device
3
| Form | Liquid | Lyophilized |
|---|---|---|
| Stabilizers | None | None |
| Preservatives | Sodium Azide | Sorbitol |
| Sodium azide | ||
| Storage | 2 to 8° C | |
| Until expiration date | 2 to 8° C | |
| Until expiration date | ||
| Open Bottle | ||
| Stability | 24 hours at 2 to 8° C | 24 hours at 2 to 8° C |
:
ﺗ
:
4
J. Conclusions '
Based upon the purpose of the device, the descriptions and labeling of the predicate device, the safety and efficacy, and the stability data generated, the product is substantially equivalent to the predicate device.
:
5
DEPARTMENT OF HEALTH & HUMAN SERVICES
Silver Spring, MD 20993
Food and Drug Administration
10903 New Hampshire Avenue
Image /page/5/Picture/2 description: The image shows the seal of the Department of Health & Human Services (HHS) of the United States. The seal features an eagle with its wings spread, symbolizing the federal government. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the eagle.
Aalto Scientific c/o Dessi Lyakov 1959 Kellogg Ave. Carlsbad. CA 92008
Re: K101216
Trade Name: Audit Micro CV Protein Linearity Set Regulation Number: 21 CFR §862.1660 Regulation Name: Quality Control. Regulatory Class: Class I, reserved Product Codes: JJY Dated: December 3, 2010 Received: December 7, 2010
JAN 1 4 20:1
Dear Ms. Lyakov:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).
6
Page 2 -
If you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and 809), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours.
GJC.
Courtney Harper, Ph.D. Director Division of Chemistry and Toxicology Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health
Enclosure
7
Indications for Use
510(k) Number: ¥10126
Device Name: Audit™ MicroCV Protein Linearity Set
Indications For Use:
The Audit™ MicroCV™ Protein Linearity is assayed quality control material consisting of five levels protein (human) based serum. Each level contains Alpha-1-Antitrypsin, Complement C3, Complement C4, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M and Transferrin analytes. The five levels demonstrate a linear relationship to each other for Alpha-1-Antitrypsin, Complement C3, Complement C4, Immunoglobulin A, Immunoglobulin A, Immunoglobulin M, and Transferrin analytes. It is intended to simulate human patient serum samples and to detect systematic analytical deviations of laboratory testing procedures for Alpha-1-Antitrypsin, Complement C3, Complement C4, Immunoglobulin G, Immunoglobulin A, Immunoglobulin M, and Transferrin. The product is intended for use with quantitative assays on the indicated analyzer provided in the labeling. The Audit MicroCV Protein Linearity Set is "For In Vitro Diagnostic Use Only."
Prescription Use _____________________________________________________________________________________________________________________________________________________________
AND/OR
Over-The-Counter Use
(Part 21 CFR 801 Subpart D)
(21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)
Signature
Division Sign-Off Office of In Vitro Diagnostic Devices Evaluation and Safety
510(k) K101216
Aalto Scientific, Ltd. 510(k) Notification Audit™ MicroCVTM Protein Linearity Set